Based on 1 analyst offering 12 month price targets for Heartsciences Inc
Min Forecast
$14.00+314.2%
Avg Forecast
$14.00+314.2%
Max Forecast
$14.00+314.2%
Should I buy or sell HSCS stock?
Based on 1 analyst offering ratings for Heartsciences Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although HSCS's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates HSCS as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More
Be the first to know when Wall Street analysts revise their HSCS stock forecasts and price targets.
Is Heartsciences Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: HSCS) stock is to Buy HSCS stock.
Out of 1 analyst, 0 (0%) are recommending HSCS as a Strong Buy, 1 (100%) are recommending HSCS as a Buy, 0 (0%) are recommending HSCS as a Hold, 0 (0%) are recommending HSCS as a Sell, and 0 (0%) are recommending HSCS as a Strong Sell.
What is HSCS's earnings growth forecast for 2026-2026?
(NASDAQ: HSCS) Heartsciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 28.56%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 54.68%.
Heartsciences's earnings in 2025 is -$8,765,229.
In 2026, HSCS is forecast to generate -$18,917,258 in earnings, with the lowest earnings forecast at -$18,917,258 and the highest earnings forecast at -$18,917,258.
What is HSCS's revenue growth forecast for 2026-2026?
(NASDAQ: HSCS) Heartsciences's forecast annual revenue growth rate of 27,486.21% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.26%, and it is also forecast to beat the US market's average forecast revenue growth rate of 119.46%.
Heartsciences's revenue in 2025 is $4,350.
In 2026, HSCS is forecast to generate $2,321,136 in revenue, with the lowest revenue forecast at $2,321,136 and the highest revenue forecast at $2,321,136.
What is HSCS's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: HSCS) forecast ROA is -447.97%, which is lower than the forecast US Medical Devices industry average of 10.3%.
What is HSCS's Price Target?
According to 1 Wall Street analyst that have issued a 1 year HSCS price target, the average HSCS price target is $14.00, with the highest HSCS stock price forecast at $14.00 and the lowest HSCS stock price forecast at $14.00.
The Wall Street analyst predicted that Heartsciences's share price could reach $14.00 by Mar 18, 2026. The average Heartsciences stock price prediction forecasts a potential upside of 300% from the current HSCS share price of $3.50.
What is HSCS's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: HSCS) Heartsciences's current Earnings Per Share (EPS) is -$9.34. In 2026, HSCS's EPS is forecast to hit -$9.78 (min: -$9.78, max: -$9.78).
What is HSCS's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: HSCS) forecast ROE is -9,220.24%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.